XTX Topco’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.1K | Buy |
91,739
+36,257
| +65% | +$26.5K | ﹤0.01% | 1963 |
|
|
2025
Q1 | $44.8K | Buy |
55,482
+8,039
| +17% | +$6.49K | ﹤0.01% | 2013 |
|
|
2024
Q4 | $65.5K | Sell |
47,443
-426,074
| -90% | -$588K | 0.01% | 1843 |
|
|
2024
Q3 | $492K | Buy |
473,517
+202,084
| +74% | +$210K | 0.04% | 828 |
|
|
2024
Q2 | $470K | Buy |
271,433
+204,391
| +305% | +$354K | 0.04% | 689 |
|
|
2024
Q1 | $160K | Sell |
67,042
-183,675
| -73% | -$439K | 0.02% | 1244 |
|
|
2023
Q4 | $835K | Buy |
250,717
+230,738
| +1,155% | +$768K | 0.18% | 56 |
|
|
2023
Q3 | $74.7K | Buy |
+19,979
| New | +$74.7K | 0.01% | 1223 |
|
|
2023
Q1 | – | Sell |
-48,756
| Closed | -$386K | – | 1315 |
|
|
2022
Q4 | $386K | Buy |
+48,756
| New | +$386K | 0.08% | 430 |
|